DNA methylation is the best‐studied epigenetic mechanism influencing pancreatic cancer development through the inactivation of tumour suppressor gene promoters, such as CDKN2A (p16INK4a) 4 and others 5. This evidence concerns the gene CDKN2A and pancreatic neoplasm.